By admin 
In a decision that fundamentally reshapes the financial landscape of the American healthcare system, the U.S. Court of Appeals for the Fifth Circuit has handed a significant legal victory to medical providers, ruling that the federal government overstepped its authority in establishing how insurers calculate payments for out-of-network care. The Tuesday ruling represents the latest and perhaps most consequential chapter in an ongoing legal battle over the implementation of the No Surprises Act (NSA), a landmark piece of consumer protection legislation designed to shield patients from the financial devastation of unexpected medical bills. While the law’s primary goal of protecting patients remains intact, the mechanics of how doctors and insurers settle their debts behind the scenes have become a high-stakes battlefield, with billions of dollars in reimbursement at stake.
The Fifth Circuit’s decision stems from a 2022 lawsuit filed by the Texas Medical Association (TMA), a perennial challenger of the government’s regulatory framework for the NSA. At the heart of the dispute is the Qualifying Payment Amount (QPA), a metric intended to represent the median in-network rate for a specific service in a given geographic area. Under the NSA’s Independent Dispute Resolution (IDR) process, third-party arbitrators use the QPA as a primary benchmark to determine how much an insurer must pay a provider for out-of-network services. Providers have long argued that the Department of Health and Human Services (HHS), along with the Departments of Labor and the Treasury, intentionally skewed the QPA calculation methodology to favor insurers, resulting in artificially depressed reimbursement rates that threaten the viability of physician practices and hospital departments.
The appellate court’s ruling addressed three specific technical aspects of the QPA calculation, siding with providers on two of the most contentious points. First, the court struck down the government’s inclusion of "ghost rates" in the QPA. Ghost rates refer to contracted prices for services that a provider does not actually perform or expect to perform, often included as placeholders in broad, multi-specialty contracts. Insurers have historically used these low, non-negotiated rates to pull down the median calculation, thereby lowering the QPA and the subsequent payments made to providers who actually specialize in those services. The Fifth Circuit found that including these irrelevant figures distorted the "median" as defined by the statute, concluding that only rates for services actually provided should be factored into the benchmark.
Secondly, the court ruled that the QPA must include bonus and incentive payments. Modern healthcare contracts frequently include performance-based modifiers, such as bonuses for meeting quality metrics or efficiency targets. The federal government’s initial rules excluded these payments from the QPA calculation, a move that providers argued ignored the reality of modern value-based care. By requiring these incentives to be factored back into the median rate, the court has effectively raised the baseline for what constitutes a "fair" payment in the eyes of the law. This change is expected to have a profound impact on specialists who operate under complex, quality-driven contracts, ensuring that the QPA more accurately reflects the total compensation insurers pay to in-network providers.
However, the court did not grant a total sweep for the healthcare industry. It sided against air ambulance providers on the issue of "one-off" rates. The providers had argued that even a single negotiated price for transporting one patient should be included in the QPA calculation. The court disagreed, maintaining that a single, non-recurring price does not constitute a "contracted rate" in the way the statute intended. This distinction highlights the court’s attempt to balance the removal of "ghost rates" with the exclusion of statistical outliers that could unfairly spike the QPA in the other direction.
The implications of this ruling extend far beyond the technicalities of insurance math. To understand the gravity of the Fifth Circuit’s decision, one must look at the broader context of the No Surprises Act’s rollout. Since the law took effect in January 2022, it has successfully prevented millions of surprise medical bills, providing peace of mind to patients who previously faced "balance billing" for emergency care or services provided by out-of-network specialists at in-network facilities. Yet, the implementation of the law’s IDR process has been plagued by administrative chaos and relentless litigation.
The Texas Medical Association has been the vanguard of this legal resistance, filing multiple lawsuits (often referred to as TMA I, II, III, and IV) to challenge various aspects of the federal rules. Previous rulings by District Judge Jeremy Kernodle in the Eastern District of Texas had already chipped away at the government’s attempts to make the QPA the "rebuttable presumption" or the primary factor in arbitration. The Fifth Circuit’s affirmation of these provider-friendly interpretations reinforces the notion that the executive branch cannot use the NSA as a back-door method for price control.
From a business perspective, the ruling is a significant boon for hospital systems and physician staffing groups, many of which are backed by private equity firms. These organizations, such as TeamHealth and Envision Healthcare, have faced immense financial pressure as the QPA-driven arbitration process resulted in lower-than-expected revenues. Critics of the ruling, including major insurance trade groups like AHIP (America’s Health Insurance Plans), argue that higher QPAs will inevitably lead to higher healthcare costs for everyone. They contend that by raising the benchmark for out-of-network payments, the court is incentivizing providers to stay out-of-network and seek higher payouts through arbitration, which will ultimately drive up insurance premiums for employers and individuals.
Data from the first two years of the NSA’s operation reveals a system under extreme stress. The federal government initially estimated that there would be roughly 17,000 IDR claims per year. Instead, the system was flooded with over 330,000 claims in the first year alone, leading to a massive backlog that has left billions of dollars in "accounts receivable" hanging in limbo for medical providers. This backlog has been exacerbated by the constant changing of the rules necessitated by court rulings like the one delivered on Tuesday. Each time a court strikes down a portion of the QPA calculation, the government must pause the IDR portal, update its guidance, and retrain arbitrators, further delaying payments.
The Fifth Circuit’s decision also touches on the broader legal shift regarding "Chevron deference," a long-standing legal principle that previously required courts to defer to federal agencies’ interpretations of ambiguous laws. With the Supreme Court’s recent moves to curtail this deference, appellate courts are becoming more aggressive in scrutinizing agency regulations. The Fifth Circuit’s opinion serves as a clear signal that the Departments of HHS, Labor, and Treasury will be held to a strict textualist interpretation of the No Surprises Act, leaving little room for the agencies to fill in the gaps with policy-driven preferences that favor one side of the industry over the other.
For patients, the immediate impact of this ruling is likely to be invisible at the point of care, as the prohibition against surprise billing remains the law of the land. However, the long-term effects are more complex. If the ruling leads to higher reimbursement rates for doctors, it may help stabilize physician practices, particularly in rural or underserved areas where thin margins often lead to facility closures. Conversely, if insurers pass these increased costs onto consumers through higher premiums and deductibles, the "protection" offered by the No Surprises Act may be offset by a general increase in the cost of maintaining health coverage.
As the healthcare industry digests the 2026 decision, all eyes turn toward the potential for a Supreme Court showdown. Given the conflicting pressures from various stakeholders and the sheer volume of litigation originating from the Fifth Circuit, the nation’s highest court may eventually be forced to provide a definitive ruling on the QPA calculation. Until then, the "business of health care" remains in a state of high-stakes flux. Hospitals and doctors will likely use this ruling to bolster their positions in upcoming contract negotiations with insurers, arguing that the era of artificially low QPAs is over. Insurers, meanwhile, will likely intensify their lobbying efforts in Washington, warning that the court’s decision has undermined the cost-saving potential of the No Surprises Act.
In the end, the Fifth Circuit has underscored a fundamental tension in American health policy: the difficulty of protecting consumers from high costs without disrupting the complex, often opaque financial relationships between those who provide care and those who pay for it. While the "ghost rates" may be disappearing from the calculations, the ghosts of past policy failures and the specter of rising premiums continue to haunt the halls of both the courtroom and the clinic. The battle over the No Surprises Act is far from over; it has merely moved into a more expensive and legally rigorous phase.
